A comprehensive clinical review published in Nature Reviews Disease Primers has consolidated the latest evidence on atopic dermatitis, the world’s most common inflammatory skin disease affecting approximately 1 in 10 people globally. The primer, authored by Prof. Stephan Weidinger and colleagues, provides clinicians and researchers with an integrated framework spanning epidemiology, pathophysiology, diagnosis, and modern therapeutic strategies.
The review underscores the multifactorial nature of atopic dermatitis, involving complex interactions between genetic predisposition, skin barrier dysfunction, and immune dysregulation. Notably, contemporary approaches now extend beyond traditional emollients to include targeted biologic therapies that address underlying disease mechanisms. The evidence demonstrates that early diagnosis combined with stratified, precision medicine approaches significantly improve both clinical outcomes and patient quality of life across multiple domains including sleep, work productivity, and psychological wellbeing.
Read the full article on GMJ Newsroom.
Was this article helpful?
